# 63323-481-57 · Epinephrine Bitartrate, Lidocaine Hydrochloride Injection · Fresenius Kabi USA, LLC — FDA drug shortage duration tracker For 63323-481-57 · Epinephrine Bitartrate, Lidocaine Hydrochloride Injection · Fresenius Kabi USA, LLC, package ndc is 63323-481-57; generic name is Epinephrine Bitartrate, Lidocaine Hydrochloride Injection; manufacturer is Fresenius Kabi USA, LLC; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01. - **Package NDC:** 63323-481-57 _(verified: appears in the quote below)_ - **Generic name:** Epinephrine Bitartrate, Lidocaine Hydrochloride Injection _(verified: appears in the quote below)_ - **Manufacturer:** Fresenius Kabi USA, LLC _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Unavailable _(verified: appears in the quote below)_ - **FDA note:** Next release September 2026. Check wholesalers for inventory. _(verified: appears in the quote below)_ - **Initial posting date:** 10/14/2016 _(verified: appears in the quote below)_ - **Last update date:** 08/25/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 3609 _(our reading, not quoted from the source)_ - **Reason for shortage:** Demand increase for the drug _(verified: appears in its own passage below)_ - **Dosage form:** Injection _(verified: appears in its own passage below)_ - **Therapeutic category:** Anesthesia _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "10/14/2016", "package_ndc": "63323-481-57", "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection", "contact_info": "888-386-1300", "availability": "Unavailable", "related_info": "Next release September 2026. Check wholesalers for inventory." ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "08/25/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)", "company_name": "Fresenius Kabi USA, LLC", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Status > "update_date": "08/25/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)", "company_name": "Fresenius Kabi USA, LLC", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Last update date > "update_date": "08/25/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)", "company_name": "Fresenius Kabi USA, LLC", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Reason for shortage > "update_date": "08/25/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)", "company_name": "Fresenius Kabi USA, LLC", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Dosage form > "update_date": "08/25/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)", "company_name": "Fresenius Kabi USA, LLC", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Therapeutic category > "update_date": "08/25/2026", "therapeutic_category": [ "Anesthesia", "Pediatric" ], "dosage_form": "Injection", "presentation": "Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)", "company_name": "Fresenius Kabi USA, LLC", "shortage_reason": "Demand increase for the drug", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-01. Review by: 2026-09-04. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).